B
LBPH

Bailard’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bailard’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,200
Closed -$110K – 847
2022
Q1 		$110K Buy
+21,200
New +$101K ﹤0.01% 691

Other funds holding LBPH

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Bailard's LBPH Position: Q2 2022 in Review

Bailard sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2022, closing a stake of 21,200 shares — an estimated $110K sold.

Bailard first reported a position in LBPH in Q1 2022 and held it in 1 quarter. The position peaked at $110K in Q1 2022. 20 funds tracked by Wall St. Rank hold LBPH as of Q2 2022.

  • Bailard reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Bailard sold 21,200 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $110K.
  • Bailard first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Bailard's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $110K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Bailard's 13F filing for Q2 2022, filed 27 Jul 2022.